Inspire Lengthens Cystic Fibrosis Study
Links shared publicly online about this topic
Inspire cystic fibrosis drug fails in key study - CharlotteObserver.com
charlotteobserver.com — “Latest health, family and wellness news from Charlotte and all of the Carolinas. | CharlotteObserver.com” View full resource at charlotteobserver.com
Most Recently Shared on January 3, 2011 at 5:39 pm By:
Drugs and Devices OW OW Health
Inspire cystic fibrosis drug fails in key study - Charlotte Observer: Inspire cystic fibrosis drug fails i... http://bit.ly/e9SS6V #drug
Inspire crushed by failed cystic fibrosis study - MarketWatch
marketwatch.com — “BOSTON (MarketWatch) -- Inspire Pharmaceuticals shares were crushed in premarket trading Monday after the biotech group reported that a Phase III clinical trial for its drug denufosol failed to show it was effective in treating cystic fibrosis. Inspire shares were down nearly 60% at $3.47. Inspire said it plans to analyze the data to determine if it will proceed with further develop the product. The company intends to issue a full corporate update in mid-February.” View full resource at marketwatch.com
Most Recently Shared on January 3, 2011 at 2:20 pm By:
ScienceintheTriangle Science Enthusiast
Inspire's CF drug fails late-stage clinical trial, shares drop 60% in premarket trading. http://bit.ly/gzggH3 and http://bit.ly/gjFOHE #SITT
Phase 3 study of denufosol tetrasodium for the treatment of cystic fibrosis (CF) - MPR
empr.com — “Inspire Pharmaceuticals announced results from its first Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis (CF).” View full resource at empr.com
Most Recently Shared on December 20, 2010 at 5:23 pm By:
MPR News: Phase 3 study of denufosol tetrasodium for the treatment of cystic fibrosis (CF): Inspire Pharmaceutic... http://bit.ly/eiFcdc
Phase 3 study of denufosol tetrasodium for the treatment of cystic fibrosis (CF) - ONA
oncologynurseadvisor.com — “Inspire Pharmaceuticals announced results from its first Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis (CF).” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 20, 2010 at 5:42 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 study of denufosol tetrasodium for the treatment of cystic fibrosis (CF) http://goo.gl/fb/GeHtO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
ScienceintheTriangle
Science writer, blogger, former N&O biotech and pharma reporter
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
